OTC seminars
This article was originally published in The Tan Sheet
Executive Summary
FDA, CHPA launching a series of seminars "to educate and inform FDA and the OTC industry on the issues specially impacting OTC drug products," agency announces May 9. "Given the...renewed interest in Rx-to-OTC switch, it behooves all of us in FDA to remain current on the issues facing the OTC industry and how we regulate it," agency says. First session will address "logistical difficulties...from the implementation of a required labeling or product change through to placement on retail shelves." Seminar will take place May 15 from 9 a.m. to 12 a.m. at FDA's offices in Rockville, Md...